377267002: Carbidopa + levodopa 50mg/200mg m/r tablet (product)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2463829019 Carbidopa + levodopa 50mg/200mg m/r tablet (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2470308015 Carbidopa + levodopa 50mg/200mg m/r tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2576154015 Co-careldopa 50mg/200mg m/r tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4725801000005114 carbidopa 50 mg + levodopa 200 mg tablet med modificeret udløsning da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
carbidopa 50 mg + levodopa 200 mg tablet med modificeret udløsning	Is a	Product containing levodopa (medicinal product)	false	Inferred relationship	Some
carbidopa 50 mg + levodopa 200 mg tablet med modificeret udløsning	Is a	Product containing carbidopa (medicinal product)	false	Inferred relationship	Some
carbidopa 50 mg + levodopa 200 mg tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Levodopa (substance)	false	Inferred relationship	Some
carbidopa 50 mg + levodopa 200 mg tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Carbidopa	false	Inferred relationship	Some
carbidopa 50 mg + levodopa 200 mg tablet med modificeret udløsning	Is a	Product containing carbidopa and levodopa (medicinal product)	false	Inferred relationship	Some
carbidopa 50 mg + levodopa 200 mg tablet med modificeret udløsning	Has manufactured dose form	A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition.	false	Inferred relationship	Some
carbidopa 50 mg + levodopa 200 mg tablet med modificeret udløsning	Has manufactured dose form	Oral tablet	false	Inferred relationship	Some
carbidopa 50 mg + levodopa 200 mg tablet med modificeret udløsning	Is a	Product manufactured as oral dose form (product)	false	Inferred relationship	Some
carbidopa 50 mg + levodopa 200 mg tablet med modificeret udløsning	Has manufactured dose form	Modified-release oral tablet (dose form)	false	Inferred relationship	Some
carbidopa 50 mg + levodopa 200 mg tablet med modificeret udløsning	Is a	Product containing carbidopa and levodopa in oral dose form (medicinal product form)	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Co-careldopa 50mg/200mg m/r tablet	Is a	False	carbidopa 50 mg + levodopa 200 mg tablet med modificeret udløsning	Inferred relationship	Some

Reference Sets

Concept inactivation indicator reference set

REPLACED BY association reference set (foundation metadata concept)